Filing Flows › Health Care › National Vision Holdings (EYE)
National Vision Holdings (EYE) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · National Vision Holdings (EYE) Q2 2026 earnings results →
Q2 2026 Revenue up 2% year over year to $499M · 2¢ of every $1 of revenue kept as net profit · operating margin 4.3%
National Vision Holdings made $499M in Q2 2026 (+2% Y/Y): Products $403M, Services and plans $95.7M. Operating margin 4.3%, net earnings $12.4M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $498.8M in Q2 2026, up 3% year over year and down 8% from the previous quarter. Products was the largest line at 81% of revenue. Products added $8.5M year over year (up 2%), 69% of the total change.
Operating profit was $21.3M, a 4.3% margin (up 0.9 points year over year). Of the extra revenue versus Q2 2025, 39% reached operating profit, above the 3% margin then. Total costs grew 2% against revenue growth of 3%. The fastest-growing cost line was Other operating costs (+15%). Net earnings were $12.4M, up 42% year over year. The effective tax rate was 30.9%.
Operating cash flow was $8.1M (down 85% year over year), 65% of net earnings. Non-cash charges added back $23.2M of depreciation and amortization and $6.4M of share-based compensation. Working capital and other items used $33.9M. Capital expenditures of $22.2M exceeded it, leaving free cash flow of −$14.1M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $499M | +2% | 4.3% | $12.4M | $8.1M |
| Q1 2026 | 10-Q | May 14, 2026 | $544M | +7% | 8.3% | $31.2M | $61.7M |
| Q4 2025 | 10-K | Mar 4, 2026 | $503M | +15% | 1.3% | $3.3M | $13.2M |
| Q3 2025 | 10-Q | Nov 6, 2025 | $487M | +8% | 2.0% | $3.4M | $46.6M |
| Q2 2025 | 10-Q | Aug 7, 2025 | $486M | +8% | 3.4% | $8.7M | $54.3M |
| Q1 2025 | 10-Q | May 8, 2025 | $510M | +6% | 5.1% | $14.2M | $32.2M |
| Q4 2024 | 10-K | Feb 26, 2025 | $437M | +4% | -5.8% | −$28.6M | $30.3M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About National Vision Holdings
National Vision Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries are referred to here as “we,” “our,” “us,” “the Company,” or “National Vision.” National Vision Holdings, Inc. conducts substantially all of its activities through its indirect, wholly-owned subsidiary, National Vision, Inc. (“NVI”), and NVI’s subsidiaries. We operate under one reportable segment, our Owned & Host segment, which includes our two owned brands, America’s Best Contacts and Eyeglasses (“America’s Best”) and Eyeglass World, as well as our Host brands, Vista Optical locations within select Fred Meyer stores and Vista Optical locations on select military bases. See Part II. Item 8. Note 15. “Segment Reporting” for more information.
In its own words, from its 10-K, filed Mar 4, 2026.
National Vision Holdings against its Ophthalmic Goods peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +2% against the peers' median +2%. Operating margin: 4.3% against the peers' median 4.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| EYE National Vision Holdings | Q2 2026 | $499M | +2% | 4.3% |
| BLCO Bausch & Lomb | Q3 2026 | $1.4B | +7% | 11.3% |
| COO Cooper Companies | Q3 FY26 | $1.1B | +0.6% | 20.8% |
| WRBY Warby Parker | Q3 2026 | $245M | +10% | 1.5% |
| STAA Staar Surgical | Q3 2026 | $83.4M | -12% | 6.5% |
| RXST RxSight | Q3 2026 | $24.6M | -19% | -75.3% |
| LUCYW Innovative Eyewear | Q2 2026 | $1.0M | +74% | -165.3% |
Source: National Vision Holdings 10-Q on SEC EDGAR · CIK 1710155 · Ophthalmic Goods
13F: who owns EYE and who is buying
More on EYE
- How National Vision Holdings makes money: revenue by segment
- National Vision Holdings next earnings date and what analysts expect
- National Vision Holdings stock forecast, price target and fair value
- Who owns National Vision Holdings stock: holders, funds and Congress trades
- Is National Vision Holdings a takeover target? LBO and rumors
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results
- National Vision Holdings operating margin by quarter
- National Vision Holdings net income by quarter
- National Vision Holdings free cash flow by quarter
- National Vision Holdings capital expenditures by quarter
- National Vision Holdings Products revenue by quarter
- National Vision Holdings Services and plans revenue by quarter